JOURNAL OF BUON, vol.18, no.3, pp.608-613, 2013 (SCI-Expanded)
Purpose: To investigate whether serum CA 15-3 and CEA levels show differences among subgroups of breast cancer patients at the time of diagnosis of early-stage disease and at disease relapse.